Our bodies are designed to fight different types of diseases using a specific protein known as an antibody. White blood cells called plasma cells are the ones that secrete the antibodies. These special proteins then race around our bloodstream searching for viruses and bacteria and destroying them. This process is part of our bodies' well-designed immune system, and while many illnesses are kept at bay, some are simply too strong for our antibodies to fight.
Scientists have identified thousands of different types of bacterial infections and viruses and are currently studying everything from variants of the common cold to serious, life-threatening viruses. The hope is that new medicines and vaccines can either lessen the effects or eradicate these illnesses. Scientists create and study polyclonal antibodies to help with this process.
To form a polyclonal antibody, highly trained laboratory workers will begin by injecting a lab rat or perhaps a mouse with an antigen. An antigen is simply a toxin that forces a body's immune system to react and create antibodies to fight the antigen. Once the antigen has been attacked and polyclonal antibodies have been formed, a blood sample is taken from the animal, and the polyclonal antibodies will then be properly purified and can be used to study the effect they have on a bacterial infection or a virus.
Typically, scientists will outsource this process to a lab that specializes in creating these helpful polyclonal antibodies. These labs offer many different types of services, including creating custom antibodies against recombinant proteins, against synthetic peptides or perhaps against a specific protein or antigen that the research team has given to the lab. This is a time consuming process, generally taking six to eight weeks from start to finish.
By studying these polyclonal antibodies, scientists create new vaccines and new antiserums to combat deadly diseases such as Ebola. There are five different known forms of Ebola, and some types have a mortality rate higher than 90%. Epidemics of Ebola have killed thousands of people worldwide, and even three lab workers have been killed after coming into contact with this highly toxic virus.
Currently, there is no vaccine or medicine that can cure or eliminate Ebola, although scientists are working diligently to find a cure or at the very least an antiserum for Ebola. An antiserum has been created using polyclonal antibodies, and has been shown to be the only effective treatment for the disease, although there has not been widespread success with this antiserum. It is hoped that by using polyclonal antibodies, medical researchers will be able to develop an antiserum that is effective and easy to replicate so that it can be used to treat millions of people successfully. It is also hoped that polyclonal antibodies can be the source of vaccines and medicines for many other diseases as well.
Scientists have identified thousands of different types of bacterial infections and viruses and are currently studying everything from variants of the common cold to serious, life-threatening viruses. The hope is that new medicines and vaccines can either lessen the effects or eradicate these illnesses. Scientists create and study polyclonal antibodies to help with this process.
To form a polyclonal antibody, highly trained laboratory workers will begin by injecting a lab rat or perhaps a mouse with an antigen. An antigen is simply a toxin that forces a body's immune system to react and create antibodies to fight the antigen. Once the antigen has been attacked and polyclonal antibodies have been formed, a blood sample is taken from the animal, and the polyclonal antibodies will then be properly purified and can be used to study the effect they have on a bacterial infection or a virus.
Typically, scientists will outsource this process to a lab that specializes in creating these helpful polyclonal antibodies. These labs offer many different types of services, including creating custom antibodies against recombinant proteins, against synthetic peptides or perhaps against a specific protein or antigen that the research team has given to the lab. This is a time consuming process, generally taking six to eight weeks from start to finish.
By studying these polyclonal antibodies, scientists create new vaccines and new antiserums to combat deadly diseases such as Ebola. There are five different known forms of Ebola, and some types have a mortality rate higher than 90%. Epidemics of Ebola have killed thousands of people worldwide, and even three lab workers have been killed after coming into contact with this highly toxic virus.
Currently, there is no vaccine or medicine that can cure or eliminate Ebola, although scientists are working diligently to find a cure or at the very least an antiserum for Ebola. An antiserum has been created using polyclonal antibodies, and has been shown to be the only effective treatment for the disease, although there has not been widespread success with this antiserum. It is hoped that by using polyclonal antibodies, medical researchers will be able to develop an antiserum that is effective and easy to replicate so that it can be used to treat millions of people successfully. It is also hoped that polyclonal antibodies can be the source of vaccines and medicines for many other diseases as well.
About the Author:
Armand Zeiders loves writing about biomedical research. For more information regarding custom monoclonal antibody production or N-Terminal sequencing services, please check out PrimmBiotech.com today.
No comments:
Post a Comment